Back to Index

NATCAPSUQ Daily Market Report

Date Range: 2025-02-14 to 2026-10-26 | Evidence Type: Daily-only

DAILY-ONLY FALLBACK: This security has current daily OHLCV history but lacks the intraday files required by the legacy execution simulator. The page therefore reports observable daily-market evidence and current research candidates only. It does not claim intraday backtest performance or a trading recommendation.

Current Snapshot

Current Snapshot — NATCAPSUQ Report
Metric Value
Latest closed session 2026-10-26
Latest close 140.2400
20-session average turnover 515866.27
Distance from 252-session high -38.21%

Trailing Price Returns

Trailing Price Returns — NATCAPSUQ Report
Sessions Return
1 -1.81%
5 -12.60%
20 -16.97%
60 -2.96%
120 -8.76%
250 -36.70%

These are trailing observations ending on the latest closed session, not forward returns from a setup.

Current Market Intelligence Candidates

Current Market Intelligence Candidates — NATCAPSUQ Report
Archetype Regime Primary horizon Strength First rejection risk
MEAN_REVERSION_CAPITULATION BEAR_PERSISTENT 20 1.78 Continued trend momentum breakdown
PRICE_DISLOCATION BEAR_PERSISTENT 120 0.38 Continued price deterioration or adverse fundamental evidence

Evidence Limits

Fundamental Research

Fundamental Research — NATCAPSUQ Report
Field Value
Statement scope FULL_STATEMENTS
Latest annual period 2026-03-31
Statement completeness 100%
Revenue growth 14.04%
Net margin -9.12%
Return on equity -7.70%
Debt/equity 0.52
Operating cash flow/net income -0.05
Free-cash-flow margin -5.70%
Trailing P/E N/A
Price/book N/A

Source: EODHD retrieved 2026-09-23T23:41:24.225155+00:00.

QA flags: balance_sheet_equation: difference=130866000.00; weak_cash_conversion: operating cash flow/net income below 0.5

Missing statements mean data is unavailable. Balance-sheet equation flags require checking accounting definitions and units. Weak cash conversion and high leverage are financial risk observations, not necessarily data errors. A summary-only record cannot establish financial quality.

Provider-standardized figures are a research aid. Review consolidated filings, units, restatements, accounting policies, and QA flags before investment use.